however, dulaglutide had a neutral effect on HF hospitalisation
The most common were gallbladder-related issues (cholecystitis, cholelithiasis) at 2.4%, consistent with other GLP-1 medications
In a medically supervised setting, programs that incorporate compounded GLP-1 may help patients feel full sooner, eat fewer calories, and build habits that support a healthier lifestyle
For example, a report of a dermal hypersensitivity reaction to dulaglutide presenting as coalescing pink macules and papules in a morbilliform pattern has been reported
In addition, several RCTs have shown that the DPP4i are also associated with lower insulin dose requirements [17,18,19]
A medication that produces major weight loss may help change future higher weight care